Newsletters 2021
Archived Newsletters from 2021
HMT Joins Global Effort to develop Covid-19 Vaccine
HMT is pleased to announce that it has signed a collaborative project agreement with AnGes, Inc. and AnGesand Osaka University for the development of a DNA vaccine against COVID-19
HMT Works from Home
During the Covid-19 crisis, we want all of our customers to know that we are still working hard from our various home offices over 5 countries worldwide, and trying to have some fun in the process!
Newsletters 2020
Archived Newsletters from 2020
Take our Metabolite Personality Quiz
Discover the metabolite most related to your personality!
HMT Young Leaders in Metabolomics Grant Awards
HMT is pleased to announce the winners of the HMT Young Leaders in Metabolomics Grant awards. We received many great proposals and look forward to working with our recipients.
Why Metabolites Matter
Check out our white paper on why metabolomics is one of the fastest growing omics
HMT Newsletter- Thanksgiving Issue 2019
Learn the importance of Tryptophan
HMT announces collaboration with J-VPD, Inc.
The scope of this collaboration agreement is to offer laboratory testing services for research and clinical purposes utilizing biomarkers for mental disorders and lifestyle related diseases. At present, we will focus on the Indian market, which is sustaining a high economic growth, and striving for commercialization.
HMT starts new collaboration with UCSF
HMT has announced it's joint collaboration with UCSF to test HMT's biomarker for Major Depressive Disorder (MDD) and identify new biomarkers for mental illness